Ann: Kazia Corporate Update and Corporate Presentation, page-7

JF's analysis may be better than than JG and there are the patent mistakes that a new CEO always makes.
They need remember that Australian FY is not the same as the calendar year.
Also page 20 bad typo to have NDA where it should be FDA.

Patient 2 on page 21 did very well looks headed to a CR. That would be game changing.

Still running out fo cash fast need a rain maker.
Also they need to join the dots to the dollars for investors.

Good luck.